Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy

Biophysical Journal

Volumn 88, Issue 6, 2005, Pages 4200-4212

  Lindgren, Mikael ^a   Sörgjerd, Karin ^b   Hammarström, Per ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DYE; PREALBUMIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANISOTROPY; ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; CROSS LINKING; DISSOCIATION CONSTANT; FAMILIAL AMYLOID POLYNEUROPATHY; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; KINETICS; MATHEMATICAL ANALYSIS; PH; PROTEIN FOLDING; PROTEIN PURIFICATION; STEADY STATE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 22244456042     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.104.049700     Document Type: Article

References (29)

1. Buxbaum, J. N. 2003. Diseases of protein conformation: what do in vitro experiments tell us about in vivo diseases? Trends Biochem. Sci. 11:585-592.
2. Conrad, R. H., and L. Brand. 1968. Intramolecular transfer of excitation from tryptophan to 1-dimethylaminonaphthalene-5-sulfonamide in a series of model compounds. Biochemistry. 7:777-787.
3. Freskgård, P. O., L. G. Mårtensson, P. Jonasson, B.-H. Jonsson, and U. Carlsson. 1994. Assignment of the contribution of the tryptophan residues to the circular dichroism spectrum of human carbonic anhydrase II. Biochemistry. 33:14281-14288.
4. Haidekker, M. A., T. Brady, K. Wen, C. Okada, H. Y. Stevens, J. M. Snell, J. A. Frangos, and E. A. Theodorakis. 2000. Phospholipid-bound molecular rotors: synthesis and characterization. Bioorg. Med. Chem. 10: 3627-3636.
5. Haidekker, M. A., T. Ling, M. Anglo, H. Y. Stevens, J. A. Frangos, and E. A. Theodorakis. 2001. New fluorescent probes for the measurement of cell membrane viscosity. Chem. Biol. 8:123-131.
6. Hammarström, P., X. Jiang, A. R. Hurshman, E. T. Powers, and J. W. Kelly. 2002. Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc. Natl. Acad. Sci. USA. 99: 16427-16432.
7. Hammarström, P., B. Kalman, B.-H. Jonsson, and U. Carlsson. 1997. Pyrene excimer fluorescence as a proximity probe for investigation of residual structure in the unfolded state of human carbonic anhydrase II. FEBS Lett. 420:63-68.
8. Hammarström, P., P. Owenius, L. G. Mårtensson, U. Carlsson, and M. Lindgren. 2001b. High-resolution probing of local conformational changes in proteins by the use of multiple labeling: unfolding and self-assembly of human carbonic anhydrase II monitored by spin, fluorescent, and chemical reactivity probes. Biophys. J. 80:2867-2885.
9. Hammarström, P., M. Persson, and U. Carlsson. 2001a. Protein compactness measured by fluorescence resonance energy transfer. Human carbonic anhydrase II is considerably expanded by the interaction of GroEL. J. Biol. Chem. 276:21765-21775.
10. Hammarström, P., M. Persson, P.-O. Freskgård, L.-G. Mårtensson, D. Andersson, B.-H. Jonsson, and U. Carlsson. 1999. Structural mapping of an aggregation nucleation site in a molten globule intermediate. J. Biol. Chem. 274:32897-32903.
11. Hammarström, P., F. Schneider, and J. W. Kelly. 2001c. Trans-suppression of misfolding in an amyloid disease. Science. 293:2459-2462.
12. Hurshman, A. R., J. T. White, E. T. Powers, and J. W. Kelly. 2004. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry. 43:7365-7381.
13. Iwaki, T., C. Torigoe, M. Noji, and M. Nakanishi. 1993. Antibodies lor fluorescent molecular rotors. Biochemistry. 32:7589-7592.
14. Kelly, J. W. 1996. Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6:11-17.
15. Kung, C. E., and J. K. Reed. 1989. Fluorescent molecular rotors: a new class of probes for tubulin structure and assembly. Biochemistry. 28: 6678-6686.
16. Lai, Z., W. Colon, and J. W. Kelly. 1996. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry. 35:6470-6482.
17. Lakowicz, J. R. 1999. Principles of Fluorescence Spectroscopy, 2nd ed. Kluwer Academic/Plenum Publishers, New York.
18. Lambert, M. P., A. K. Barlow, B. A. Chromy, C. Edwards, R. Freed, M. Liosatos, T. E. Morgan, I. Rozovsky, B. Trommer, K. L. Viola, P. Wals, C. Zhang, and others. 1998. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA. 95:6448-6453.
19. Lashuel, H. A., C. Wurth, L. Woo, and J. W. Kelly. 1999. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions. Biochemistry. 38:13560-13573.
20. LeVine, H. 1993. Thioflavine T interaction with synthetic Alzheimer's disease b-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2:404-410.
21. Loutfy, R. O. 1986. Fluorescent probes for polymer free-volume. Pure Appl. Chem, 58:1239-1248.
22. Naiki, H., K. Higuchi, M. Hosokawa, and T. Takeda. 1989. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, Thioflavine T. Anal. Biochem. 177:244-249.
23. Nilsson, S. F., L. Rask, and P. A. Peterson. 1975. Studies on thyroid hormone-binding proteins. II. Binding of thyroid hormones, retinol-binding protein, and fluorescent probes to prealbumin and effects of thyroxine on prealbumin subunit self association. J. Biol. Chem. 250: 8554-8563.
24. Sawada, S., T. Iio, Y. Hayashi, and S. Takahashi. 1992. Fluorescent rotors and their applications to the study of G-F transformation of Actin. Anal. Biochem. 204:110-117.
25. Semisotnov, G. V., N. A. Rodionova, O. I. Razgulyaev, V. N. Uversky, A. F. Gripas', and R. I. Gilmanshin. 1991. Study of the "molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers. 31:119-128.
26. Sousa, M. M., I. Cardoso, R. Fernandes, A. Guimaraes, and M. J. Saraiva. 2001. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am. J. Pathol. 159:1993-2000.
27. Svensson, M., P. Jonasson, P.-O. Freskgård, B.-H. Jonsson, M. Lindgren, L.-G. Mårtensson, M. Gentile, K. Borén, and U. Carlsson. 1995. Mapping the folding intermediate of human carbonic anhydrase II. Probing substructure by chemical reactivity and spin and fluorescence labeling of engineered cysteine residues. Biochemistry. 34:8606-8620.
28. Westermark, P., K. Sletten, B. Johansson, and G. G. Cornwell. 1990. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. USA. 87:2843-2845.
29. Wojtczak, A., J. Luft, and V. Cody. 1992. Mechanism of molecular recognition. Structural aspects of 3,3′-diiodo-L-thyronine binding to human serum transthyretin. J. Biol. Chem. 267:353-357.